Cordlife stands firm on offer price for StemLife as deadline looms


One of the cryo containers that store umbilical cord blood and bone marrow samples at the private cord blood bank StemLife Bhd in Kuala Lumpur. The samples are kept in the stacked metal boxes to the left of the cylinder.

If Cordlife gets less than 90%, Bursa Securities may impose additional conditions for the withdrawal of StemLife’s listing status. A listed company also may not withdraw its listing unless, among others, the withdrawal resolution must be made at an EGM where it is approved by 75% in value of shareholders and holders of any other class of listed securities.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Malaysia's economy grows 6.3% in 4Q, above forecast
Hock Soon Capital falls 7c below IPO on debut
Ringgit opens firmer on weaker US$, 4Q GDP optimism
FBM KLCI seen consolidating ahead of GDP release, CNY holiday
Trading ideas: Steel Hawk, Critical, GDB, Hextar Industries, Infraharta, MFM, MGB, Oriental, UEM Sunrise, Maxis, SKP
Steel Hawk unit secures PETRONAS deal
Dialog enters recovery year driven by midstream recurring income
Stunning 4Q finish for Malaysia
Topmix posts record quarterly revenue and earnings
SC appoints LC Wakaful Digital as first social exchange operator

Others Also Read